| 06/01 | AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains Add Recommendation | MT |
| 05/31 | Analysts recommendations: Asos, Burberry, Chevron, Microsoft, N.. | |
| 05/22 | Wedbush Trims AVROBIO's PT to $2 From $4 on Heels of Announced Sale of Cystinosis Gene .. | MT |
| 05/19 | NOVARTIS AG : JP Morgan sticks Neutral | MD |
| 05/18 | NOVARTIS AG : UBS remains Neutral | MD |
| 05/02 | NOVARTIS AG : Jefferies keeps its Buy rating | MD |
| 04/26 | NOVARTIS AG : Credit Suisse maintains a Sell rating | MD |
| 04/26 | NOVARTIS AG : Barclays gives a Sell rating | MD |
| 04/26 | Morningstar Downgrades Novartis to Sell From Buy, $90 Price Target | MT |
| 04/26 | Credit Suisse Boosts Price Target on Novartis to CHF90 From CHF80 on Higher Earnings, M.. | MT |
| 04/26 | NOVARTIS AG : JP Morgan reiterates its Neutral rating | MD |
| 04/26 | Credit Suisse Lifts Price Target on Novartis, Maintains Underperform Recommendation | MT |
| 04/26 | Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation | MT |
| 04/26 | Novartis : Capable of reaching newer highs | |
| 04/26 | NOVARTIS AG : Raised to Buy by Deutsche Bank | MD |
| 04/25 | Novartis : Q1 beat, guidance upgraded, re-rating to continue | |
| 04/25 | NOVARTIS AG : Jefferies keeps its Buy rating | MD |
| 04/21 | Kepler Cheuvreux Lifts Price Target on Novartis, Maintains Buy Recommendation | MT |
| 04/18 | NOVARTIS AG : Gets a Buy rating from Jefferies | MD |
| 04/12 | NOVARTIS AG : Gets a Neutral rating from JP Morgan | MD |
| 04/11 | Barclays Lifts Price Target on Novartis, Maintains Underweight Recommendation | MT |
| 04/11 | NOVARTIS AG : Barclays reiterates its Sell rating | MD |
| 03/28 | NOVARTIS AG : UBS sticks Neutral | MD |
| 03/28 | Oddo BHF Lifts Price Target on Novartis, Maintains Neutral Recommendation | MT |
| 03/28 | NOVARTIS AG : Deutsche Bank Upgrades to Neutral | MD |
| 03/27 | NOVARTIS AG : Jefferies gives a Buy rating | MD |
| 03/20 | Novartis : Markets have high expectations of the Swiss giant | |
| 03/14 | NOVARTIS AG : Deutsche Bank reaffirms its Sell rating | MD |
| 02/23 | AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains Add Recommendation | MT |
| 02/17 | NOVARTIS AG : Deutsche Bank reaffirms its Sell rating | MD |
| 02/13 | NOVARTIS AG : Goldman Sachs reaffirms its Buy rating | MD |
| 02/07 | NOVARTIS AG : Deutsche Bank gives a Sell rating | MD |
| 02/06 | NOVARTIS AG : Berenberg reaffirms its Neutral rating | MD |
| 02/03 | NOVARTIS AG : JP Morgan sticks Neutral | MD |
| 02/03 | DA Davidson Raises Novartis AG PT to $95 From $90 After Higher-Than-Consensus Q4 2022 C.. | MT |
| 02/02 | NOVARTIS AG : Receives a Sell rating from Credit Suisse | MD |
| 02/02 | NOVARTIS AG : Deutsche Bank reiterates its Sell rating | MD |
| 02/02 | Novartis : Mixed Q4, but targeted improvements hold the key | |
| 02/01 | NOVARTIS AG : Gets a Buy rating from Goldman Sachs | MD |
| 02/01 | NOVARTIS AG : Jefferies reaffirms its Buy rating | MD |
| 02/01 | NOVARTIS AG : Gets a Neutral rating from UBS | MD |
| 01/27 | Novartis : Reassessing Novartis’ investment worthiness | |
| 01/25 | NOVARTIS AG : Sell rating from Barclays | MD |
| 01/24 | NOVARTIS AG : Goldman Sachs reiterates its Buy rating | MD |
| 01/09 | NOVARTIS AG : UBS sticks Neutral | MD |
| 01/06 | NOVARTIS AG : Receives a Sell rating from Credit Suisse | MD |
| 01/06 | NOVARTIS AG : Morgan Stanley downgrades from Neutral to Sell | MD |
| 01/05 | NOVARTIS AG : Jefferies maintains a Buy rating | MD |
| 01/03 | NOVARTIS AG : JP Morgan drops its Sell rating | MD |
| 2022 | NOVARTIS AG : Sell rating from Barclays | MD |
| 2022 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation | MT |
| 2022 | AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains Add Recommendation | MT |
| 2022 | Zacks Lifts Price Target on Novartis, Maintains Neutral Recommendation | MT |
| 2022 | NOVARTIS AG : UBS reiterates its Neutral rating | MD |
| 2022 | NOVARTIS AG : Receives a Buy rating from Jefferies | MD |
| 2022 | NOVARTIS AG : Deutsche Bank keeps a Sell rating | MD |
| 2022 | NOVARTIS AG : Gets a Neutral rating from Bernstein | MD |
| 2022 | NOVARTIS AG : Receives a Buy rating from Goldman Sachs | MD |
| 2022 | NOVARTIS AG : Gets a Sell rating from Deutsche Bank | MD |
| 2022 | NOVARTIS AG : Berenberg European Conference | FA |
| 2022 | NOVARTIS AG : UBS reiterates its Neutral rating | MD |
| 2022 | BNP Paribas Lowers Price Target on Novartis, Maintains Neutral Recommendation | MT |
| 2022 | Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation | MT |
| 2022 | Stifel Upgrades Recommendation on Novartis to Buy From Hold | MT |
| 2022 | Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation | MT |
| 2022 | NOVARTIS AG : Gets a Sell rating from Deutsche Bank | MD |
| 2022 | Stifel Lifts Price Target on Novartis, Maintains Hold Recommendation | MT |
| 2022 | Roche’s Alzheimer’s failure has sector-wide implications | |
| 2022 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation | MT |
| 2022 | Zacks Lifts Price Target on Novartis, Maintains Neutral Recommendation | MT |
| 2022 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation | MT |
| 2022 | NOVARTIS AG : Gets a Sell rating from Deutsche Bank | MD |
| 2022 | NOVARTIS AG : Bernstein reaffirms its Neutral rating | MD |
| 2022 | NOVARTIS AG : Credit Suisse maintains a Sell rating | MD |
| 2022 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
